ROIVANT SCIENCES LTD. Shares Outstanding (Cover Page)
ROIVANT SCIENCES LTD. (ROIV) had Shares Outstanding (Cover Page) of 722.32 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 722.32M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 719.27M shares.
- 2026-02-02: Entity Common Stock, Shares Outstanding 715.70M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 695.49M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 722.32M shares 10-Q · filed 2026-08-06 |
| 2026-05-12 | 719.27M shares 10-K · filed 2026-05-20 |
| 2026-02-02 | 715.70M shares 10-Q · filed 2026-02-06 |
| 2025-11-03 | 695.49M shares 10-Q · filed 2025-11-10 |
| 2025-08-06 | 682.88M shares 10-Q · filed 2025-08-11 |
| 2025-05-21 | 679.81M shares 10-K · filed 2025-05-29 |
| 2025-02-06 | 713.55M shares 10-Q · filed 2025-02-10 |
| 2024-11-08 | 727.95M shares 10-Q · filed 2024-11-12 |
| 2024-08-06 | 739.52M shares 10-Q · filed 2024-08-09 |
| 2024-05-28 | 738.72M shares 10-K · filed 2024-05-30 |
| 2024-02-09 | 805.85M shares 10-Q · filed 2024-02-13 |
| 2023-11-09 | 803.92M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 771.74M shares 10-Q · filed 2023-08-14 |
| 2023-06-26 | 766.81M shares 10-K · filed 2023-06-28 |
| 2023-02-09 | 758.43M shares 10-Q · filed 2023-02-13 |
| 2022-11-10 | 725.42M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 703.63M shares 10-Q · filed 2022-08-15 |
| 2022-06-21 | 700.77M shares 10-K · filed 2022-06-28 |
| 2022-02-09 | 692.07M shares 10-Q · filed 2022-02-14 |
| 2021-11-10 | 684.79M shares 10-Q · filed 2021-11-15 |
| 2021-09-20 | 222.67M shares 10-Q · filed 2021-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |